Is It a Good Time to Be a Pharmacist in the US?

por Walton, Surrey M., Manasse, Henri R.
Publicado 2018

Cost-Effectiveness Analysis and the Formulary Decision-Making Process

por Wang, Zhixiao, Salmon, J. Warren, Walton, Surrey M.
Publicado 2004

Quantifying weight loss program preferences of men working in trade and labor occupations: A discrete choice experiment

por Crane, Melissa M., Walton, Surrey M., Suzuki, Sumihiro, Appelhans, Bradley M.
Publicado 2022

A Case Study in Generic Drug Use: Should There Be Risk Adjustment in Incentive Payments for the Use of Generic Medications?

por Walton, Surrey M., Rash, Christine, Lambert, Bruce L., Galanter, William L.
Publicado 2014

Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?

por Pickard, A Simon, Wang, Zhixiao, Walton, Surrey M, Lee, Todd A
Publicado 2005

An initial evaluation of expanded hemodialysis on hospitalizations, drug utilization, costs, and patient utility in Colombia

por Ariza, Juan G., Walton, Surrey M., Suarez, Adriana M., Sanabria, Mauricio, Vesga, Jasmin I.
Publicado 2021

The effectiveness and value of emicizumab and valoctocogene roxaparvovec for the management of hemophilia A without inhibitors: A summary from the Institute for Clinical and Econom...

por Agboola, Foluso, Rind, David M, Walton, Surrey M, Herron-Smith, Serina, Quach, Danny, Pearson, Steven D
Publicado 2021

The Effectiveness and Value of Deflazacort and Exon-Skipping Therapies for the Management of Duchenne Muscular Dystrophy: A Summary from the Institute for Clinical and Economic Re...

por Agboola, Foluso, Lin, Grace A., Fluetsch, Noemi, Walton, Surrey M., Rind, David M., Pearson, Steven D.
Publicado 2020

Type 2 diabetes mellitus burdens among adults with sickle cell disease: A 12‐year single health system‐based cohort analysis

por Zhou, Jifang, Calip, Gregory S., Nutescu, Edith A., Han, Jin, Walton, Surrey M., Srisuwananukorn, Andrew, Galanter, William L.
Publicado 2021

Adherence and Persistence with DPP-4 Inhibitors Versus Pioglitazone in Type 2 Diabetes Patients with Chronic Kidney Disease: A Retrospective Claims Database Analysis

por Gor, Deval, Lee, Todd A., Schumock, Glen T., Walton, Surrey M., Gerber, Ben S., Nutescu, Edith A., Touchette, Daniel R.
Publicado 2020

Comparison of 6-Month Costs Between Oral Antiplatelet Agents Following Acute Coronary Syndrome

por Kim, Kibum, Lee, Todd A., Touchette, Daniel R., DiDomenico, Robert J., Ardati, Amer K., Walton, Surrey M.
Publicado 2018

Quantitative revenue estimates and qualitative assessments of innovative fundraising sources for treating rare diseases in Colombia

por Walton, Surrey M, Mayorga, Wilson, Narváez, Angela Rodríguez, Chavez, Maria Alejandra, Guesguán, Natalia Cortés, Durango, Luis, Parada, Ludy Alexandra
Publicado 2023

The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

por Tice, Jeffrey A, Walton, Surrey M, Sarker, Jyotirmoy, Moradi, Ashton, Chu, Janet N, Herce-Hagiwara, Belen, Fahim, Shahariar Mohammed, Agboola, Foluso, Rind, David, Pearson, Steven D
Publicado 2023

Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States

por Carlson, Josh J., Walton, Surrey M., Basu, Anirban, Chapman, Richard H., Campbell, Jonathan D., McQueen, R. Brett, Pearson, Steven D., Touchette, Daniel R., Veenstra, David, Whittington, Melanie D., Ollendorf, Daniel A.
Publicado 2019